Results 251 to 260 of about 4,403,667 (297)

Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience

open access: yesOncology, 2022
<b><i>Introduction:</i></b> Non-small cell lung cancer (NSCLC) accounts for most lung cancers and is a leading cause of cancer-related deaths in the USA. Alterations in c-MET, a tyrosine kinase receptor, have been involved in many cases of NSCLC progression and metastasis.
Muhammed Iraqi, Nir Peled, Waleed Kian
exaly   +3 more sources

Home - About - Disclaimer - Privacy